AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2217
-0.0052 (-2.29%)
Sep 11, 2026, 4:00 PM EDT - Market closed
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $6.75 million as of September 11, 2026. Its market cap has decreased by -5.73% in one year.
Market Cap
6.75M
Enterprise Value
706.02K
1-Year Change
-5.73%
Ranking
Category
Stock Price
$0.22
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $6.75M, a decrease of -83.48%. That is a compound annual growth rate of -5.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 6.75M | 109.34% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 7.81M |
| Bolt Biotherapeutics | 7.61M |
| Acurx Pharmaceuticals | 7.38M |
| Ernexa Therapeutics | 6.80M |
| CollPlant Biotechnologies | 6.62M |
| Lexaria Bioscience | 6.56M |
| Enveric Biosciences | 6.36M |
| Creative Medical Technology Holdings | 6.33M |